PAI-1, an inflammatory adipokine and a recognized biomarker of metabolic syndrome [40,41], is closely associated with cardiovascular disease, hepatic steatosis, dyslipidemia, and adipose tissue dysfunction [42,43,44]. This evidence concerns the gene SERPINE1 and Hepatic steatosis.